Scarica l'app Stockscreener
1,054.29
0.74%
-7.90
Dopo l'orario di chiusura:
1052.20
-2.09
-0.20%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
3 Unstoppable Vanguard ETFs to Buy Even if There's a Stock Market Sell-Off in 2026 - The Motley Fool
Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly - CNBC
Eli Lilly and Company Stock (LLY) Opinions on Retatrutide Trial Results - Quiver Quantitative
Is Eli Lilly a Buy Before 2026? - AOL.com
Eli Lilly's next-generation obesity drug secures first phase III win - MSN
Eli Lilly Stock (LLY) News, Forecasts and Outlook — Updated Dec. 16, 2025 - ts2.tech
Eli Lilly Shares Surge on Analyst Upgrade and Promising Drug Data - AD HOC NEWS
Lilly to participate in J.P. Morgan Healthcare Conference - marketscreener.com
Lilly leads with massive 15% dividend increase for 2026 - Rolling Out
Eli Lilly or Merck: Where Should Investors Put Their Money? - TradingView — Track All Markets
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More - AOL.com
Watts Gwilliam & Co. LLC Reduces Position in Eli Lilly and Company $LLY - MarketBeat
Lilly weight loss drug exceeds targets in Phase III trial - Longevity.Technology
The Alabama insider behind Eli Lilly’s $6 billion bet - Yellowhammer News
Rydar Equities Inc. Invests $1.25 Million in Eli Lilly and Company $LLY - MarketBeat
Why Is Novo Nordisk Stock Falling Tuesday?Eli Lilly (NYSE:LLY), Novo Nordisk (NYSE:NVO) - Benzinga
LLY: Lawsuits Over Vision Loss Consolidated for Eli Lilly's Weig - GuruFocus
Eli Lilly and Company $LLY Shares Purchased by Corient Private Wealth LLC - MarketBeat
Where Will Eli Lilly Be in 10 Years? - Yahoo Finance
Analyst recommendations: Accenture, Albemarle, Eli Lilly, Gitlab, Okta… - marketscreener.com
Central Pacific Bank Trust Division Increases Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Two Engines Drive the Future, Market Continues Betting on Lilly - NAI500
Scotiabank remains bullish on Eli Lilly and Company (LLY) - MSN
Scotiabank Remains Bullish on Eli Lilly and Company (LLY) - Finviz
Eli Lilly (LLY): Revisiting Valuation After a Powerful Multi‑Month Share Price Rally - simplywall.st
Eli Lilly and Company (NYSE:LLY) Stock Price Up 3.4%Time to Buy? - MarketBeat
Top 20 by Trading Value | Accelerated Commercialization of FSD Boosts Tesla Over 3% to New Yearly High; Faster Approval Process for Weight-Loss Drugs Lifts Eli Lilly and Co Over 3%, Market Cap Breaks $1 Trillion Mark Again; NVIDIA Launches Next-Gen - 富途牛牛
Eli Lilly Stock (LLY) After Hours Today: What to Know Before the Market Opens Tuesday, Dec. 16, 2025 - ts2.tech
Eli Lilly & Co. stock outperforms competitors on strong trading day - MSN
2 Predictions for Eli Lilly in 2026 - AOL.com
Bank of America Says Market Isn’t Pricing in Eli Lilly’s (LLY) Weight-Loss Drug Dominance - TipRanks
Why Eli Lilly (LLY) Stock Is Trading Up Today - Finviz
Eli Lilly's Obesity Drug Dominance Still Underpriced By Market, Bank of America Says - Benzinga
Eli Lilly's GLP-1 Franchise to Drive 26% Revenue Growth in 2026, BofA Securities Says - marketscreener.com
Eli Lilly Stock (LLY) News Today: Retatrutide Breakthrough, Orforglipron FDA Timeline, and Analyst Forecasts on December 15, 2025 - ts2.tech
Eli Lilly (LLY): B of A Securities Lowers Price Target Despite Buy Rating | LLY Stock News - GuruFocus
Lilly Building $6B Huntsville Pharma Plant - Connect CRE
V. M. Manning & CO. Inc. Invests $875,000 in Eli Lilly and Company $LLY - MarketBeat
Bank of America Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price - MarketBeat
Eli Lilly and Company (NYSE:LLY) Stock Unloaded Rep. Julie Johnson - MarketBeat
Eli Lilly price target raised to $1,145 from $951 at Goldman Sachs - TipRanks
Eli Lilly and Company $LLY Shares Purchased by NWF Advisory Services Inc. - MarketBeat
Silicon Valley Capital Partners Boosts Position in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Purchased by SevenBridge Financial Group LLC - MarketBeat
126,836 Shares in Eli Lilly and Company $LLY Acquired by Munro Partners - MarketBeat
Eli Lilly & Co: Strategic Initiatives and Promising Market Opportunities Drive Buy Rating - TipRanks
Thrivent Financial for Lutherans Acquires 52,783 Shares of Eli Lilly and Company $LLY - MarketBeat
MASTERINVEST Kapitalanlage GmbH Acquires New Holdings in Eli Lilly and Company $LLY - MarketBeat
Kentucky Retirement Systems Sells 3,363 Shares of Eli Lilly and Company $LLY - MarketBeat
Serafino FabianoBizTimes - BizTimes - Milwaukee Business News
Eli Lilly just delivered fantastic news to investors - MSN
Eli Lilly Just Delivered Fantastic News to Investors - Finviz
Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade) (NYSE:LLY) - Seeking Alpha
Cim Investment Management Inc. Has $3.12 Million Stake in Eli Lilly and Company $LLY - MarketBeat
American Trust Buys 3,644 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly (LLY) Expands Mounjaro Use to Younger Patients in Euro - GuruFocus
Eli Lilly’s Retatrutide Study: A New Hope for CKD Treatment? - TipRanks
Eli Lilly’s New Study on Obesity Drug LY4167586: What Investors Need to Know - TipRanks
Eli Lilly’s New Study on LY3549492: A Potential Breakthrough in Obesity Treatment - TipRanks
Eli Lilly Completes Phase 1 Study of Eloralintide for Obesity in China - TipRanks
Eli Lilly Weight Loss Drug Shows Impressive Results in Phase 3 Trial - InsideHook
Eli Lilly Stock (LLY) News, Forecasts and Analyst Outlook — Retatrutide Breakthrough, Orforglipron FDA Timeline, and a $6B Manufacturing Bet (Dec. 14, 2025) - ts2.tech
Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus - MSN
Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025) - ts2.tech
2.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):